Your browser doesn't support javascript.
loading
Lenalidomide Enhances CAR-T Cell Activity Against Solid Tumor Cells.
Wang, Zhixiong; Zhou, Guomin; Risu, Na; Fu, Jiayu; Zou, Yan; Tang, Jiaxing; Li, Long; Liu, Hui; Liu, Qian; Zhu, Xuekai.
Afiliação
  • Wang Z; School of Medical Instrument and Food Engineering, 47863University of Shanghai for Science and Technology, China.
  • Zhou G; Ma'anshan University, China.
  • Risu N; Division of Health Science, Graduate School of Medicine, 13013Osaka University, Japan.
  • Fu J; School of Medical Instrument and Food Engineering, 47863University of Shanghai for Science and Technology, China.
  • Zou Y; Division of Health Science, Graduate School of Medicine, 13013Osaka University, Japan.
  • Tang J; Division of Health Science, Graduate School of Medicine, 13013Osaka University, Japan.
  • Li L; Shanghai Institute for Advanced Immunochemical Studies (SIAIS), 387433ShanghaiTech University, China.
  • Liu H; Shanghai Institute for Advanced Immunochemical Studies (SIAIS), 387433ShanghaiTech University, China.
  • Liu Q; Shanghai Institute for Advanced Immunochemical Studies (SIAIS), 387433ShanghaiTech University, China.
  • Zhu X; School of Medical Instrument and Food Engineering, 47863University of Shanghai for Science and Technology, China.
Cell Transplant ; 29: 963689720920825, 2020.
Article em En | MEDLINE | ID: mdl-32967454

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Lenalidomida / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Lenalidomida / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article